"My doctor has changed my pills without telling me": impact of generic medication switches in stroke survivors

Julie A Chambers, Ronan E. O'Carroll, Martin Dennis, Cathie Sudlow, Marie Johnston

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Generic (i.e. non-branded medicine) and therapeutic (i.e. a less expensive drug from the same class) substitution of medication provides considerable financial savings, but may negatively impact on patients. We report secondary qualitative/quantitative analysis of stroke survivors from a pilot randomised controlled brief intervention to increase adherence to medication. Patients’ experiences of medication changes were examined in conjunction with electronically-recorded medication adherence. Twenty-eight patients reported frequent medication changes (e.g. size/shape/colour/packaging) and two-thirds of these reported negative effects, resulting in, at least, confusion and, at worst, mistakes in medication-taking. Patients reporting a direct effect on their medication-taking (n = 6) demonstrated poorer objectively-measured adherence (i.e. % doses taken on schedule) than those reporting confusion [mean difference = 19.9, 95 % CI (2.0, 37.8)] or no problems [mean difference = 20.6, 95 % CI (1.6, 40.0)]. Changes to medication resulting from switching between generic brands can be associated with notable problems, including poorer medication adherence, for a significant minority.
Original languageEnglish
Pages (from-to)890-901
Number of pages12
JournalJournal of Behavioral Medicine
Volume37
Issue number5
Early online date14 Dec 2013
DOIs
Publication statusPublished - Oct 2014

Fingerprint

Medication Adherence
Survivors
Stroke
Confusion
Product Packaging
Appointments and Schedules
Color
Medicine
Pharmaceutical Preparations
Therapeutics

Keywords

  • stroke
  • adherence
  • medication
  • generic substitution
  • therapeutic substitution

Cite this

"My doctor has changed my pills without telling me" : impact of generic medication switches in stroke survivors. / Chambers, Julie A; O'Carroll, Ronan E.; Dennis, Martin; Sudlow, Cathie; Johnston, Marie.

In: Journal of Behavioral Medicine, Vol. 37, No. 5, 10.2014, p. 890-901.

Research output: Contribution to journalArticle

Chambers, Julie A ; O'Carroll, Ronan E. ; Dennis, Martin ; Sudlow, Cathie ; Johnston, Marie. / "My doctor has changed my pills without telling me" : impact of generic medication switches in stroke survivors. In: Journal of Behavioral Medicine. 2014 ; Vol. 37, No. 5. pp. 890-901.
@article{86ebc89f14f842889846f5a96555966e,
title = "{"}My doctor has changed my pills without telling me{"}: impact of generic medication switches in stroke survivors",
abstract = "Generic (i.e. non-branded medicine) and therapeutic (i.e. a less expensive drug from the same class) substitution of medication provides considerable financial savings, but may negatively impact on patients. We report secondary qualitative/quantitative analysis of stroke survivors from a pilot randomised controlled brief intervention to increase adherence to medication. Patients’ experiences of medication changes were examined in conjunction with electronically-recorded medication adherence. Twenty-eight patients reported frequent medication changes (e.g. size/shape/colour/packaging) and two-thirds of these reported negative effects, resulting in, at least, confusion and, at worst, mistakes in medication-taking. Patients reporting a direct effect on their medication-taking (n = 6) demonstrated poorer objectively-measured adherence (i.e. {\%} doses taken on schedule) than those reporting confusion [mean difference = 19.9, 95 {\%} CI (2.0, 37.8)] or no problems [mean difference = 20.6, 95 {\%} CI (1.6, 40.0)]. Changes to medication resulting from switching between generic brands can be associated with notable problems, including poorer medication adherence, for a significant minority.",
keywords = "stroke, adherence, medication, generic substitution, therapeutic substitution",
author = "Chambers, {Julie A} and O'Carroll, {Ronan E.} and Martin Dennis and Cathie Sudlow and Marie Johnston",
note = "This project was funded by a grant from the Scottish Government, Department of Health, Chief Scientist Office; reference number CZH/4/569. We would like to thank the doctors and nurses at the Western General Hospital stroke clinic and ward for their help in recruitment, and the patients for giving up their time to take part.",
year = "2014",
month = "10",
doi = "10.1007/s10865-013-9550-5",
language = "English",
volume = "37",
pages = "890--901",
journal = "Journal of Behavioral Medicine",
issn = "0160-7715",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - "My doctor has changed my pills without telling me"

T2 - impact of generic medication switches in stroke survivors

AU - Chambers, Julie A

AU - O'Carroll, Ronan E.

AU - Dennis, Martin

AU - Sudlow, Cathie

AU - Johnston, Marie

N1 - This project was funded by a grant from the Scottish Government, Department of Health, Chief Scientist Office; reference number CZH/4/569. We would like to thank the doctors and nurses at the Western General Hospital stroke clinic and ward for their help in recruitment, and the patients for giving up their time to take part.

PY - 2014/10

Y1 - 2014/10

N2 - Generic (i.e. non-branded medicine) and therapeutic (i.e. a less expensive drug from the same class) substitution of medication provides considerable financial savings, but may negatively impact on patients. We report secondary qualitative/quantitative analysis of stroke survivors from a pilot randomised controlled brief intervention to increase adherence to medication. Patients’ experiences of medication changes were examined in conjunction with electronically-recorded medication adherence. Twenty-eight patients reported frequent medication changes (e.g. size/shape/colour/packaging) and two-thirds of these reported negative effects, resulting in, at least, confusion and, at worst, mistakes in medication-taking. Patients reporting a direct effect on their medication-taking (n = 6) demonstrated poorer objectively-measured adherence (i.e. % doses taken on schedule) than those reporting confusion [mean difference = 19.9, 95 % CI (2.0, 37.8)] or no problems [mean difference = 20.6, 95 % CI (1.6, 40.0)]. Changes to medication resulting from switching between generic brands can be associated with notable problems, including poorer medication adherence, for a significant minority.

AB - Generic (i.e. non-branded medicine) and therapeutic (i.e. a less expensive drug from the same class) substitution of medication provides considerable financial savings, but may negatively impact on patients. We report secondary qualitative/quantitative analysis of stroke survivors from a pilot randomised controlled brief intervention to increase adherence to medication. Patients’ experiences of medication changes were examined in conjunction with electronically-recorded medication adherence. Twenty-eight patients reported frequent medication changes (e.g. size/shape/colour/packaging) and two-thirds of these reported negative effects, resulting in, at least, confusion and, at worst, mistakes in medication-taking. Patients reporting a direct effect on their medication-taking (n = 6) demonstrated poorer objectively-measured adherence (i.e. % doses taken on schedule) than those reporting confusion [mean difference = 19.9, 95 % CI (2.0, 37.8)] or no problems [mean difference = 20.6, 95 % CI (1.6, 40.0)]. Changes to medication resulting from switching between generic brands can be associated with notable problems, including poorer medication adherence, for a significant minority.

KW - stroke

KW - adherence

KW - medication

KW - generic substitution

KW - therapeutic substitution

U2 - 10.1007/s10865-013-9550-5

DO - 10.1007/s10865-013-9550-5

M3 - Article

VL - 37

SP - 890

EP - 901

JO - Journal of Behavioral Medicine

JF - Journal of Behavioral Medicine

SN - 0160-7715

IS - 5

ER -